What is HeadSense's primary focus?

HeadSense Medical is developing a noninvasive intracranial pressure (ICP) monitor designed to assist in treating patients with severe traumatic brain injury (TBI), stroke, and brain tumors.

When was HeadSense founded?

HeadSense was founded in April 2011.

What is the current status of HeadSense?

HeadSense is currently inactive, as of November 2017.

Where is HeadSense headquartered?

HeadSense is headquartered in Netanya, Center District, Israel.

How many employees did HeadSense have?

HeadSense had an employee count in the 11-50 range.

What is the core technology behind HeadSense's product?

The HeadSense ICP monitor uses an acoustic signal transmitted into the ear and through the skull, picked up by a sensor in the other ear. A proprietary signal-processing algorithm then analyzes this signal to provide ICP levels.

Which investors participated in HeadSense's July 2013 funding round?

In July 2013, HeadSense received funding from investors including GE Ventures and Pontifax.

Did HeadSense receive any grants?

Yes, HeadSense received a Grant in November 2013 from the Office of the Chief Scientist.

HeadSense

Noninvasive Multiparameter Brain Monitoring

Health Tech & Life Sciences

Non Active, Nov 2017

Mature Netanya, Israel Founded 2011

Last updated 2026-06-18

Raised grant, Nov 2013
Raised funding round, Jul 2013

Total raised

—

Last: Grant 2013-11

Stage

Mature

Founded

2011

Headcount

Netanya, Israel

Sector

Health Tech & Life Sciences

About

HeadSense Medical is developing a noninvasive intracranial pressure (ICP) monitor to help treat patients with severe traumatic brain injury (TBI), stroke, and brain tumors. The HeadSense ICP monitor contains a disposable unit similar to a headset which allows continuous ICP monitoring. The device emits an acoustic signal which is transmitted into the ear and through the skull, then picked up in the other ear by a sensor. The signal is analyzed using a proprietary signal-processing algorithm that provides the ICP levels in mmHg. Data analysis and display can be performed on a tablet or smartphone.

Funding history · 2 rounds · — total

2013-11

Grant Undisclosed

Office of the Chief Scientist

2013-07

Undisclosed

GE Ventures Pontifax Everett Partners

Q&A

What is HeadSense's primary focus?: HeadSense Medical is developing a noninvasive intracranial pressure (ICP) monitor designed to assist in treating patients with severe traumatic brain injury (TBI), stroke, and brain tumors.
When was HeadSense founded?: HeadSense was founded in April 2011.
What is the current status of HeadSense?: HeadSense is currently inactive, as of November 2017.
Where is HeadSense headquartered?: HeadSense is headquartered in Netanya, Center District, Israel.
How many employees did HeadSense have?: HeadSense had an employee count in the 11-50 range.
What is the core technology behind HeadSense's product?: The HeadSense ICP monitor uses an acoustic signal transmitted into the ear and through the skull, picked up by a sensor in the other ear. A proprietary signal-processing algorithm then analyzes this signal to provide ICP levels.
Which investors participated in HeadSense's July 2013 funding round?: In July 2013, HeadSense received funding from investors including GE Ventures and Pontifax.
Did HeadSense receive any grants?: Yes, HeadSense received a Grant in November 2013 from the Office of the Chief Scientist.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical Monitors

Technologies

Sensing

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Identifiers & details

Founded	2011-4
Employees (exact)	31
Offices	USA
Status reason	Non Active, Nov 2017

About

Funding history · 2 rounds · — total

Q&A

Sectors & technology

Tags

Identifiers & details

Generate Slim Page